Table 1.
Mean ± SD or N (%) | Correlation coefficient, p values | ||
---|---|---|---|
Demographic characteristics | Age at MRI (years) | 49.04 ± 6.89 | −0.37, <0.001 |
Education (years) | 15 ± 2 | −0.09, 0.38 | |
Female | 42 (48%) | 0.12, 0.27 | |
| |||
Diabetes-related factors and complications | T1D duration at MRI (years) | 40.80 ± 6.26 | 0.28, 0.01 |
Age at T1D diagnosis (years) | 8.24 ± 4.25 | 0.18, 0.10 | |
Serum glucose (mg/dL) | 177.52 ± 90.68 | −0.06, 0.61 | |
HbA1c (%) | 7.96 ± 2.32 | 0.15, 0.17 | |
HbA1c months (AU) | 971.15 ± 374.24 | 0.32, <0.001 | |
Confirmed distal symmetric polyneuropathy∗ | 38 (48%) | 0.38, <0.001 | |
Overt nephropathy∗ | 23 (32%) | 0.33, <0.001 | |
Proliferative retinopathy∗ | 39 (45%) | 0.36, <0.001 | |
| |||
MRI measures | Correct median response time (ms) | 1353.39 ± 322.12 | — |
White matter hyperintensity volume (% total brain volume) | 0.002 ± 0.003 | 0.24, 0.02 | |
White matter hyperintensity severity, Fazekas rating = 3 | 10 (11%) | 0.25, 0.02 | |
| |||
Cognitive measures | NAART (verbal IQ estimate) | 108 ± 7 | −0.17, 0.14 |
Digit symbol substitution test, number complete in 90 seconds (pencil and paper test) | 56 ± 13 | −0.56, <0.001 | |
Information processing domain, z-score | 0.54 ± 0.82 | −0.57, <0.001 | |
Clinically relevant cognitive impairment | 28 (35%) | 0.37, <0.001 |
∗Documented in 2004–2006.